Insider · CIK 0001652659
Peter L Sefzik
officer
Files at CMA (COMERICA INC /NEW/). First filing May 5, 2025, latest May 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.1M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | CMAsell COMERICA INC /NEW/ | $1.1M 19,941 shares | -30% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 1, 2025 | CMA COMERICA INC /NEW/ | SOpen-market sale Common Stock | -19,636 | $54.63 | $1.1M | 47,630 | May 5, 2025 |
| May 1, 2025 | CMA COMERICA INC /NEW/ | SOpen-market sale Common Stock | -305 | $54.94 | $17k | 47,325 | May 5, 2025 |
| Feb 20, 2025 | CMA COMERICA INC /NEW/ | AGrant or award Common Stock | +9,625 | $0.00 | $0 | 71,054 | Feb 24, 2025 |
| Feb 20, 2025 | CMA COMERICA INC /NEW/ | FTax withholding Common Stock | -3,788 | $67.01 | $254k | 67,266 | Feb 24, 2025 |
| Jan 28, 2025 | CMA COMERICA INC /NEW/ | FTax withholding Common Stock | -235 | $63.53 | $15k | 51,354 | Jan 30, 2025 |
| Jan 28, 2025 | CMA COMERICA INC /NEW/ | AGrant or award Common Stock | +10,075 | $0.00 | $0 | 61,429 | Jan 30, 2025 |
| Jan 24, 2025 | CMA COMERICA INC /NEW/ | FTax withholding Common Stock | -425 | $63.27 | $27k | 53,037 | Jan 28, 2025 |
| Jan 24, 2025 | CMA COMERICA INC /NEW/ | FTax withholding Common Stock | -351 | $63.27 | $22k | 52,686 | Jan 28, 2025 |
| Jan 24, 2025 | CMA COMERICA INC /NEW/ | FTax withholding Common Stock | -1,097 | $63.27 | $69k | 51,589 | Jan 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.